# US 2024/0025832 A1 · Processes and intermediates for the preparation of carbaprostacyclin analogues

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0025832 A1
- Document ID: US20240025832A1
- Status: Published application
- Kind: A1
- Application number: 18/476,137
- Filed: 2023-09-27
- Published: 2024-01-25
- Earliest claimed: 2022-05-05
- Assignees: Chirogate International Inc.
- Applicants: Chirogate International Inc.
- Inventors: CHUN-YU LIN; TZYH-MANN WEI; SHIH-YI WEI
- Web page: https://patentgrep.com/patent/US20240025832A1

## CPC

- C07C 49/743: having unsaturation outside the rings, e.g. humulones, lupulones
- C07D 307/16: Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07C 33/12: containing five-membered rings
- C07C 49/707: a keto group being part of a three- to five-membered ring
- C07C 51/09: from carboxylic acid esters or lactones
- C07C 59/46: containing rings other than six-membered aromatic rings
- C07C 59/62: containing rings other than six-membered aromatic rings
- C07C 59/74: containing —CHO groups
- C07C 67/333: by isomerisation; by change of size of the carbon skeleton (introduction or elimination of carboxyl groups C07C67/313, C07C67/32)
- C07C 69/732: of unsaturated hydroxy carboxylic acids
- C07C 69/738: Esters of keto-carboxylic acids {or aldehydo-carboxylic acids}
- C07C 405/00: Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins {; Analogues or derivatives thereof}
- C07D 307/42: Singly bound oxygen atoms
- C07F 7/1804: {Compounds having Si-O-C linkages (Si-O-acyl linkages C07F7/1896)}
- C07F 7/188: {by reactions involving the formation of Si-O linkages}
- C07F 7/1892: {by reactions not provided for in C07F7/1876 - C07F7/1888}
- C12P 7/26: Ketones
- C12P 7/38: Cyclopentanone- or cyclopentadione-containing products
- C12P 7/62: Carboxylic acid esters
- C12P 41/004: {by esterification of alcohol- or thiol groups in the enantiomers or the inverse reaction}
- C07C 2602/22: the ring system containing eight carbon atoms, e.g. pentalene
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- C07F: ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM (metal-containing porphyrins C07D487/22)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}

## Abstract

The invention relates to processes for preparing carbaprostacyclin analogues and intermediates prepared from the processes. The invention also relates to cyclopentenone intermediates in racemic or optically active form.

## Claims

### Claim 1

A compound of Formula 2:
wherein Y is —CH2OP or —COOR1; X is F, Cl, Br, I, or —OTs; P is H or a hydroxyl protective group; R1 is C1-7-alkyl, aryl or aralkyl, each of which is unsubstituted or substituted by C1-4-alkyl, C2-7-alkenyl, C2-7-alkynyl, nitro, halogen or alkoxy; R2 is H or C1-4-alkyl; and R3 is C1-7-alkyl, C2-7-alkynyl, aryl, or aryloxy, each of which is unsubstituted or substituted by C1-4-alkyl, halogen, or a trihalomethyl.

### Claim 2 (depends on 1)

The compound according to claim 1, which is a compound of Formula 2a:
wherein Y is —CH2OP or —COOR1; X is F, Cl, Br, I, or —OTs; P is H or a hydroxyl protective group; and R1 is C1-7-alkyl, aryl or aralkyl, each of which is unsubstituted or substituted by C1-4-alkyl, C2-7-alkenyl, C2-7-alkynyl, nitro, halogen or alkoxy.

### Claim 3 (depends on 1)

The compound according to claim 1, which is the compound of Formula 2b:
wherein Y is —CH2OP or —COOR1; X is F, Cl, Br, I, or —OTs; P is H or a hydroxyl protective group; and R1 is C1-7-alkyl, aryl or aralkyl, each of which is unsubstituted or substituted by C1-4-alkyl, C2-7-alkenyl, C2-7-alkynyl, nitro, halogen or alkoxy.

### Claim 4

A compound of Formula 3 or Formula 3″:
wherein Y is —CH2OP or —COOR1; X is F, Cl, Br, I, or —OTs; Z is H or a sulfonyl group; P is H or a hydroxyl protective group; R1 is C1-7-alkyl, aryl or aralkyl, each of which is unsubstituted or substituted by C1-4-alkyl, C2-7-alkenyl, C2-7-alkynyl, nitro, halogen or alkoxy; R2 is H or C1-4-alkyl; and R3 is C1-7-alkyl, C2-7-alkynyl, aryl, or aryloxy, each of which is unsubstituted or substituted by C1-4-alkyl, halogen, or trihalomethyl.

### Claim 5 (depends on 4)

The compound according to claim 4, which is the compound of Formula 3:
wherein Y is —CH2OP or —COOR1; X is F, Cl, Br, I, or —OTs; P is H or a hydroxyl protective group; R1 is C1-7-alkyl, aryl or aralkyl, each of which is unsubstituted or substituted by C1-4-alkyl, C2-7-alkenyl, C2-7-alkynyl, nitro, halogen or alkoxy; R2 is H or C1-4-alkyl; and R3 is C1-7-alkyl, C2-7-alkynyl, aryl, or aryloxy, each of which is unsubstituted or substituted by C1-4-alkyl, halogen or trihalomethyl.

### Claim 6 (depends on 5)

The compound according to claim 5, which is a compound of Formula 3a:
wherein Y is —CH2OP or —COOR1; X is F, Cl, Br, I, or —OTs; P is H or a hydroxyl protective group; and R1 is C1-7-alkyl, aryl or aralkyl, each of which is unsubstituted or substituted by C1-4-alkyl, C2-7-alkenyl, C2-7-alkynyl, nitro, halogen or alkoxy.

### Claim 7 (depends on 5)

The compound according to claim 5, which is a compound of Formula 3b:
wherein Y is —CH2OP or —COOR1; X is F, Cl, Br, I, or —OTs; P is H or a hydroxyl protective group; and R1 is C1-7-alkyl, aryl or aralkyl, each of which is unsubstituted or substituted by C1-4-alkyl, C2-7-alkenyl, C2-7-alkynyl, nitro, halogen or alkoxy.

### Claim 8 (depends on 4)

The compound according to claim 4, which is the compound of Formula 3″:
wherein Y is —CH2OP or —COOR1; X is F, Cl, Br, I, or —OTs; Z is H or a sulfonyl group; P is H or a hydroxyl protective group; R1 is C1-7-alkyl, aryl or aralkyl, each of which is unsubstituted or substituted by C1-4-alkyl, C2-7-alkenyl, C2-7-alkynyl, nitro, halogen or alkoxy; R2 is H or C1-4-alkyl; and R3 is C1-7-alkyl, C2-7-alkynyl, aryl, or aryloxy, each of which is unsubstituted or substituted by C1-4-alkyl, halogen, or trihalomethyl.

### Claim 9 (depends on 8)

The compound according to claim 8, which is a compound of Formula 3′a:
wherein Y is —CH2OP or —COOR1; X is F, Cl, Br, I, or —OTs; Z is H or a sulfonyl group; P is H or a hydroxyl protective group; and R1 is C1-7-alkyl, aryl or aralkyl, each of which is unsubstituted or substituted by C1-4-alkyl, C2-7-alkenyl, C2-7-alkynyl, nitro, halogen or alkoxy.

### Claim 10 (depends on 8)

The compound according to claim 8, which is a compound of Formula 3′b:
wherein Y is —CH2OP or —COOR1; X is F, Cl, Br, I, or —OTs; Z is H or a sulfonyl group;
P is H or a hydroxyl protective group; and R1 is C1-7-alkyl, aryl or aralkyl, each of which is unsubstituted or substituted by C1-4-alkyl, C2-7-alkenyl, C2-7-alkynyl, nitro, halogen or alkoxy.

### Claim 11

A compound of Formula A2 or Formula A8:
wherein Y is —CH2OP or —COOR1; X is F, Cl, Br, I, or —OTs; P is H or a hydroxyl protective group; and R1 is C1-7-alkyl, aryl or aralkyl, each of which is unsubstituted or substituted by C1-4-alkyl, C2-7-alkenyl, C2-7-alkynyl, nitro, halogen or alkoxy.

### Claim 12 (depends on 11)

The compound according to claim 11, which is the compound of Formula A2:
wherein Y is —CH2OP or —COOR1; X is F, Cl, Br, I, or —OTs; P is H or a hydroxyl protective group; and R1 is C1-7-alkyl, aryl or aralkyl, each of which is unsubstituted or substituted by C1-4-alkyl, C2-7-alkenyl, C2-7-alkynyl, nitro, halogen or alkoxy.

### Claim 13 (depends on 11)

The compound according to claim 11, which is the compound of Formula A8:
wherein Y is —CH2OP or —COOR1; X is F, Cl, Br, I, or —OTs; P is H or a hydroxyl protective group; and R1 is C1-7-alkyl, aryl or aralkyl, each of which is unsubstituted or substituted by C1-4-alkyl, C2-7-alkenyl, C2-7-alkynyl, nitro, halogen or alkoxy.
